Julie B. Feder

This profile gathers the share dealings of Julie B. Feder in Aura Biosciences, Inc., where the filings describe the role as finance chief. The record holds 9 filings, for trades running from 28 October 2021 to 18 October 2024.

The open-market record consists of 4 sales worth €137k, with no purchase. The rest of the record consists of 3 share grants and 2 option exercises. So far in 2024, the count stands at no purchases and 1 sale.

Most recently, on 21 October 2024, the filings show an option exercise worth €44k in Aura Biosciences, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.